Doctors and patients one step closer to getting information on effectiveness and side effects of medicine. 

The Senate Health Committee passed the Pharmaceutical Drug Information and Safety Act, SB 606 (Scott), which will require pharmaceutical companies to make the clinical studies they conduct publicly available.

“This year has been dubbed the ‘year of health reform’ by Governor Schwarzenegger, and this bill is a big part of it,” said Steve Blackledge. “Our doctors need complete information when they make prescribing decisions, and many consumers want the same information before walking into a pharmacy to get a prescription filled.”

In testimony, Blackledge noted that in the case of Vioxx, the drug’s maker had uncovered information in a clinical study showing an increased risk of heart attack and stroke, but Merck was not required to make that information public. Meanwhile, the company continued to tout its drug, even going so far as to put out a news release with the headline, “Merck Confirms Favorable Cardiovascular Safety Profile of Vioxx.”

Supporting the bill in addition to CALPIRG were the California Board of Pharmacy (a board within the California Department of Consumer Affairs), Consumers Union, California Labor Federation (AFL-CIO), Health Access, Congress of California Seniors, the California Association of Retired Americans, AIDS Health Care Foundation, Consumer Federation of California and others.

Voting for the measure were Senators Sheila Kuehl (chair), Elaine Alquist, Gil Cedillo, Mark Ridley-Thomas, Darrell Steinberg, and Leland Yee.

“We thank Senator Scott for his perseverance on this bill, and we thank the senators who stood up to the drug industry and its lobbyists and passed this meaningful protection,” added Blackledge. “Their efforts and votes help to ensure that patients will get the safest, most effective prescriptions possible.”

The bill moves to the Senate floor next.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Merck to pay $830 million to settle investors’ Vioxx...

Merck announced Friday it will pay $830 million to settle investor complaints accusing it of committing...

Merck to pay nearly $1 billion for illegal marketing...

American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal...

Merck paying more than 3,100 vioxx death claims

Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who...

Settlement limits insurers' claims in Vioxx deal

TRENTON, N.J. (AP) -- Former Vioxx users getting part of a $4.85 billion settlement ending most personal...

Persistence pays in Vioxx litigation

Plaintiffs get close to $5B, but Merck could have done a lot worse. Attorneys who spent nearly one year...

Vioxx settlement payments to begin in August

Merck & Co., manufacturer of Vioxx, announced it will make the first payment of $500 million on Aug....

A positive manner

Several years ago my brother and sister -in-law were in a terrible car accident. My sister in-law was paralyzed from her neck down. Beasley Allen handled the case for my brother to see to it that my sister-in-law received the proper and necessary care she needed. I appreciate the attorneys and staff of Beasley Allen in handling this matter quickly and in a positive manner. Good job Beasley Allen!!

—Joan